11 results on '"Relander T"'
Search Results
2. Late relapses in peripheral T-cell lymphoma patients treated in the nordic NLG-T-01 trial
3. First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma PatientsTreated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy
4. Upfront Autologuos Stem Cell Transplantation in Peripheral T-cell Lymphoma (NLG-T-01)
5. High-dose chemotherapy and autologous stem cell transplantation in previously untreated peripheral T-cell lymphoma - final analysis of a large prospective multicenter study (NLG-T-01)
6. Alemtuzumab does not affect hematopoietic recovery after autologous stem cell transplantation in T-cell lymphoma: Data from the ACT-1 trial
7. First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant
8. CHOEP-14 and autologous stem cell tranplantation (ASCT) in angioimmunoblastic T-cell lymphoma: a prospective study by the Nordic Lymphoma Group (NLG-T-01)
9. Hemopoetic Stem Cell Transplantation in T-Cell Malignancies: Who, When and How?
10. Overexpression of gibbon ape leukemia viral (GALV) receptor on human CD34+ cells increases gene transfer mediated by GALV pseudotyped vectors
11. Setback for gene therapy: Two cases of leukemia in a French study,Bakslag för genterapi: Två fall av leukemi i fransk studie
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.